Neutrophilic Granule Protein (Ngp) stands as a pivotal player in cellular regulation, exerting its influence through the facilitation of cysteine-type endopeptidase inhibitor activity. The intricacies of its predicted function involve the negative regulation of angiogenesis and lymphangiogenesis, processes critical to the cellular microenvironment. Ngp achieves this by actively participating in cellular locations such as the cytoplasmic vesicle and extracellular space, with notable expression in the liver and liver lobe. The key function of Ngp lies in its ability to inhibit cysteine-type endopeptidases, thereby acting as a safeguard against untimely enzymatic degradation. This inhibition not only preserves the integrity of Ngp but also positively influences critical cellular processes, emphasizing its significance in maintaining cellular homeostasis.
The activation of Ngp unfolds through a sophisticated web of mechanisms that shield it from enzymatic degradation. Chemical modulators, which act as direct activators, play a crucial role in this process. These compounds intricately interact with the cysteine-type endopeptidases, effectively inhibiting their activity. By preventing the enzymatic degradation of Ngp, these activators enhance its stability and contribute to the finely tuned regulation of angiogenesis and lymphangiogenesis. The dynamic network of endopeptidase inhibitors, exemplified by these chemical activators, showcases the complex interplay of molecular events that govern Ngp activation. Understanding these intricate mechanisms unveils the nuanced ways in which Ngp contributes to the orchestration of cellular processes, offering valuable insights into potential avenues for further research and exploration in the realm of cellular regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | $275.00 $928.00 $1543.00 | 14 | |
E-64 activates Ngp by inhibiting cysteine-type endopeptidases. By preventing enzymatic degradation of Ngp, E-64 enhances its stability, positively influencing cellular processes related to angiogenesis and lymphangiogenesis regulation in both the cytoplasmic vesicle and extracellular space. | ||||||
Leupeptin hemisulfate | 103476-89-7 | sc-295358 sc-295358A sc-295358D sc-295358E sc-295358B sc-295358C | 5 mg 25 mg 50 mg 100 mg 500 mg 10 mg | $72.00 $145.00 $265.00 $489.00 $1399.00 $99.00 | 19 | |
Leupeptin activates Ngp by inhibiting cysteine-type endopeptidases. By preventing the enzymatic degradation of Ngp, Leupeptin enhances its stability, positively influencing cellular processes related to angiogenesis and lymphangiogenesis regulation in both the cytoplasmic vesicle and extracellular space. | ||||||
Z-FA-FMK | 197855-65-5 | sc-201303 sc-201303A | 1 mg 5 mg | $125.00 $365.00 | 19 | |
Z-FA-FMK activates Ngp by inhibiting cysteine-type endopeptidases. By preventing enzymatic degradation, Z-FA-FMK enhances Ngp stability, positively influencing cellular processes related to angiogenesis and lymphangiogenesis regulation in both the cytoplasmic vesicle and extracellular space. | ||||||
ALLM (Calpain Inhibitor) | 136632-32-1 | sc-201268 sc-201268A | 5 mg 25 mg | $140.00 $380.00 | 23 | |
ALLM activates Ngp by inhibiting cysteine-type endopeptidases. By blocking enzymatic degradation, ALLM enhances Ngp stability, positively influencing cellular processes related to angiogenesis and lymphangiogenesis regulation in both the cytoplasmic vesicle and extracellular space. | ||||||